1630 related articles for article (PubMed ID: 28152446)
21. Cardamonin, a natural flavone, alleviates inflammatory bowel disease by the inhibition of NLRP3 inflammasome activation via an AhR/Nrf2/NQO1 pathway.
Wang K; Lv Q; Miao YM; Qiao SM; Dai Y; Wei ZF
Biochem Pharmacol; 2018 Sep; 155():494-509. PubMed ID: 30071202
[TBL] [Abstract][Full Text] [Related]
22. Therapeutic Efficacy of the Traditional Chinese Medicine Baishaoqiwu on TNBS-induced Colitis is Associated with Down-regulation of the TLR4/MyD88/NF-κB Signaling Pathway.
Xu X; Zhang L; Liu Z; Pan Y; Chen D; Yang Z; Deng Q; Cao X; Sun YU; Yang Z; Hoffman RM; Yuan H
In Vivo; 2016; 30(3):181-6. PubMed ID: 27107073
[TBL] [Abstract][Full Text] [Related]
23. Curcumin improves TNBS-induced colitis in rats by inhibiting IL-27 expression via the TLR4/NF-κB signaling pathway.
Zeng Z; Zhan L; Liao H; Chen L; Lv X
Planta Med; 2013 Jan; 79(2):102-9. PubMed ID: 23250811
[TBL] [Abstract][Full Text] [Related]
24. Amelioration of trinitrobenzene sulfonic acid-induced colitis in mice by liquiritigenin.
Min JK; Lee CH; Jang SE; Park JW; Lim SJ; Kim DH; Bae H; Kim HJ; Cha JM
J Gastroenterol Hepatol; 2015 May; 30(5):858-65. PubMed ID: 25311527
[TBL] [Abstract][Full Text] [Related]
25. Fucoxanthin from microalgae Phaeodactylum tricornutum inhibits pro-inflammatory cytokines by regulating both NF-κB and NLRP3 inflammasome activation.
Lee AH; Shin HY; Park JH; Koo SY; Kim SM; Yang SH
Sci Rep; 2021 Jan; 11(1):543. PubMed ID: 33436909
[TBL] [Abstract][Full Text] [Related]
26. Polysaccharide from Scutellaria baicalensis Georgi ameliorates colitis via suppressing NF-κB signaling and NLRP3 inflammasome activation.
Cui L; Wang W; Luo Y; Ning Q; Xia Z; Chen J; Feng L; Wang H; Song J; Tan X; Tan W; Wang C; Jia X
Int J Biol Macromol; 2019 Jul; 132():393-405. PubMed ID: 30936012
[TBL] [Abstract][Full Text] [Related]
27. Oridonin derivative ameliorates experimental colitis by inhibiting activated T-cells and translocation of nuclear factor-kappa B.
Liu QQ; Wang HL; Chen K; Wang SB; Xu Y; Ye Q; Sun YW
J Dig Dis; 2016 Feb; 17(2):104-12. PubMed ID: 26718746
[TBL] [Abstract][Full Text] [Related]
28. Canna x generalis L.H. Bailey rhizome extract ameliorates dextran sulfate sodium-induced colitis via modulating intestinal mucosal dysfunction, oxidative stress, inflammation, and TLR4/ NF-ҡB and NLRP3 inflammasome pathways.
Mahmoud TN; El-Maadawy WH; Kandil ZA; Khalil H; El-Fiky NM; El Alfy TSMA
J Ethnopharmacol; 2021 Apr; 269():113670. PubMed ID: 33301917
[TBL] [Abstract][Full Text] [Related]
29. Atorvastatin suppresses NLRP3 inflammasome activation via TLR4/MyD88/NF-κB signaling in PMA-stimulated THP-1 monocytes.
Kong F; Ye B; Lin L; Cai X; Huang W; Huang Z
Biomed Pharmacother; 2016 Aug; 82():167-72. PubMed ID: 27470352
[TBL] [Abstract][Full Text] [Related]
30. [Electroacupuncture of "Shangjuxu"(ST37) and "Tianshu"(ST25) reduces colonic injury by suppressing NF-κB/NLRP3 signaling in rats with ulcerative colitis].
Cao QR; Ling C; Liu MJ; Zhang H; Deng SF
Zhen Ci Yan Jiu; 2022 Apr; 47(4):314-20. PubMed ID: 35486010
[TBL] [Abstract][Full Text] [Related]
31. A novel benzo[d]imidazole derivate prevents the development of dextran sulfate sodium-induced murine experimental colitis via inhibition of NLRP3 inflammasome.
Liu W; Guo W; Wu J; Luo Q; Tao F; Gu Y; Shen Y; Li J; Tan R; Xu Q; Sun Y
Biochem Pharmacol; 2013 May; 85(10):1504-12. PubMed ID: 23506741
[TBL] [Abstract][Full Text] [Related]
32. Resolvin D1 inhibits inflammatory response in STZ-induced diabetic retinopathy rats: Possible involvement of NLRP3 inflammasome and NF-κB signaling pathway.
Yin Y; Chen F; Wang W; Wang H; Zhang X
Mol Vis; 2017; 23():242-250. PubMed ID: 28465656
[TBL] [Abstract][Full Text] [Related]
33. Chikusetsu saponin IVa ameliorates high fat diet-induced inflammation in adipose tissue of mice through inhibition of NLRP3 inflammasome activation and NF-κB signaling.
Yuan C; Liu C; Wang T; He Y; Zhou Z; Dun Y; Zhao H; Ren D; Wang J; Zhang C; Yuan D
Oncotarget; 2017 May; 8(19):31023-31040. PubMed ID: 28415686
[TBL] [Abstract][Full Text] [Related]
34. GEN-27 exhibits anti-inflammatory effects by suppressing the activation of NLRP3 inflammasome and NF-κB pathway.
Hu M; Li X; Zhang J; Yuan Z; Fu Y; Ma X; Ren N
Cell Biol Int; 2019 Oct; 43(10):1184-1192. PubMed ID: 30632647
[TBL] [Abstract][Full Text] [Related]
35. Magnesium isoglycyrrhizinate blocks fructose-induced hepatic NF-κB/NLRP3 inflammasome activation and lipid metabolism disorder.
Zhao XJ; Yang YZ; Zheng YJ; Wang SC; Gu HM; Pan Y; Wang SJ; Xu HJ; Kong LD
Eur J Pharmacol; 2017 Aug; 809():141-150. PubMed ID: 28526339
[TBL] [Abstract][Full Text] [Related]
36. Sinigrin inhibits production of inflammatory mediators by suppressing NF-κB/MAPK pathways or NLRP3 inflammasome activation in macrophages.
Lee HW; Lee CG; Rhee DK; Um SH; Pyo S
Int Immunopharmacol; 2017 Apr; 45():163-173. PubMed ID: 28219839
[TBL] [Abstract][Full Text] [Related]
37. Aloe vera downregulates LPS-induced inflammatory cytokine production and expression of NLRP3 inflammasome in human macrophages.
Budai MM; Varga A; Milesz S; Tőzsér J; Benkő S
Mol Immunol; 2013 Dec; 56(4):471-9. PubMed ID: 23911403
[TBL] [Abstract][Full Text] [Related]
38. Growth differentiation factor 11 ameliorates experimental colitis by inhibiting NLRP3 inflammasome activation.
Wang L; Wang Y; Wang Z; Qi Y; Zong B; Liu M; Li X; Zhang X; Liu C; Cao R; Ma Y
Am J Physiol Gastrointest Liver Physiol; 2018 Dec; 315(6):G909-G920. PubMed ID: 30188752
[TBL] [Abstract][Full Text] [Related]
39. Combination therapy of mesenchymal stromal cells and sulfasalazine attenuates trinitrobenzene sulfonic acid induced colitis in the rat: The S1P pathway.
Yousefi-Ahmadipour A; Rashidian A; Mirzaei MR; Farsinejad A; PourMohammadi-Nejad F; Ghazi-Khansari M; Ai J; Shirian S; Allahverdi A; Saremi J; Ebrahimi-Barough S
J Cell Physiol; 2019 Jul; 234(7):11078-11091. PubMed ID: 30580446
[TBL] [Abstract][Full Text] [Related]
40. Melatonin ameliorates TNBS-induced colitis in rats through the melatonin receptors: involvement of TLR4/MyD88/NF-κB signalling pathway.
Chamanara M; Rashidian A; Mehr SE; Dehpour AR; Shirkohi R; Akbarian R; Abdollahi A; Rezayat SM
Inflammopharmacology; 2019 Apr; 27(2):361-371. PubMed ID: 30143913
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
